These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23411684)

  • 1. Effect of rapamycin-induced tumor vessel thrombosis combined with docetaxel in non-small-cell lung cancer.
    Xu L; Qin Y; Huang J; Qin J; Gu J; Zhu H; Liu H; Cai Y; Wu X; Feng J
    Anticancer Drugs; 2013 Apr; 24(4):406-14. PubMed ID: 23411684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
    Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.
    Goto H; Yano S; Zhang H; Matsumori Y; Ogawa H; Blakey DC; Sone S
    Cancer Res; 2002 Jul; 62(13):3711-5. PubMed ID: 12097279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.
    Yin H; Guo R; Xu Y; Zheng Y; Hou Z; Dai X; Zhang Z; Zheng D; Xu H
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):147-53. PubMed ID: 22126905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.
    Yap R; Veliceasa D; Emmenegger U; Kerbel RS; McKay LM; Henkin J; Volpert OV
    Clin Cancer Res; 2005 Sep; 11(18):6678-85. PubMed ID: 16166447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
    Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
    Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model.
    Wu H; Xin Y; Zhao J; Sun D; Li W; Hu Y; Wang S
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):879-87. PubMed ID: 21290245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
    Xie CY; Xu YP; Jin W; Lou LG
    Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
    Wu H; Xin Y; Xiao Y; Zhao J
    Cancer Biother Radiopharm; 2012 Apr; 27(3):204-9. PubMed ID: 22283637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
    Lu Z; Wientjes TS; Au JL
    Pharm Res; 2005 Jul; 22(7):1069-78. PubMed ID: 16028007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
    Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel.
    Agata N; Nogi H; Bamberg M; Milhollen M; Pu M; Weitman S; Kharbanda S; Kufe D
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):610-4. PubMed ID: 15947930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics.
    Rosetti M; Zoli W; Tesei A; Ulivi P; Fabbri F; Vannini I; Brigliadori G; Granato AM; Amadori D; Silvestrini R
    J Cell Physiol; 2007 Sep; 212(3):710-6. PubMed ID: 17458894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.
    Marimpietri D; Brignole C; Nico B; Pastorino F; Pezzolo A; Piccardi F; Cilli M; Di Paolo D; Pagnan G; Longo L; Perri P; Ribatti D; Ponzoni M
    Clin Cancer Res; 2007 Jul; 13(13):3977-88. PubMed ID: 17606732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo.
    Mukhopadhyay T; Sasaki J; Ramesh R; Roth JA
    Clin Cancer Res; 2002 Sep; 8(9):2963-9. PubMed ID: 12231542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
    Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
    Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer.
    Aftab BT; Dobromilskaya I; Liu JO; Rudin CM
    Cancer Res; 2011 Nov; 71(21):6764-72. PubMed ID: 21896639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.